Clinical Trial Update: A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of switching from Tenofovir Disoproxil Fumarate to Tenofovir Disoproxil in chronic hepatitis B patients has been co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• Tenofovir disoproxil switch (tenofovir disoproxil)

Snippet

Sponsor: Samjin Pharmaceutical Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED